CEO SUMMARY: Pathology laboratories are enjoying steady increases in specimen volume and revenue as new molecular assays gain acceptance by clinicians. However, the supply of histotechnologists is failing to keep pace with growth in the volume of tissue-based testing. One executive who places histotechs into laboratories predicts that competition among labs for skilled histotechs will […]
To access this post, you must purchase The Dark Report.